The immunolabelling intensity of GDF9 and BMP15 between groups Parameter Control (n=80) Vehicle (n=80) GDF9 33.72[+ or -]11.22 33.95[+ or -]10.75 (pixel) BMP15 31.12[+ or -]11.05 29.99[+ or -]10.72 (pixel) Parameter PCOS (n=80) p value GDF9 27.73 (a)[+ or -]8.43 0.001 (pixel) BMP15 24.85 (a)[+ or -]7.03 0.001 (pixel) Values represent mean [+ or -] standard deviation; (a) p<0.05 is significantly different; GDF9: growth differentiation factor 9
; BMP15: bone morphogenetic protein 15; PCOS: Polycystic ovary syndrome TABLE 2.
Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants.
Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage.
Expression of Growth Differentiation Factor 9 messenger RNA in porcine growing and preovulatory ovarian follicles.
Expression of growth differentiation factor 9 (GDF9), and bone morphogenetic protein 15 (BMP-15), and BMP receptors in the ovaries of goats.
Molecular characterisation of growth differentiation factor 9
(gdf9) and bone morphogenetic protein 15 (bmp15) and their patterns of gene expression during the ovarian reproductive cycle in the European sea bass.